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ABSTRACT
In the lungs, vascular endothelial cells experience cyclic mechanical strain resulting from rhythmic breathing motions and intraluminal
blood pressure. Mechanical stress creates evident physiological, morphological, biochemical, and gene expression changes in vascular
endothelial cells. However, the exact mechanisms of the mechanical signal transduction into biological responses remain to be clarified.
Besides, the level of mechanical stress is difficult to determine due to the complexity of the local distension patterns in the lungs and thus
assumed to be the same as the one acting on the alveolar epithelium. Existing in vitro models used to investigate the effect of mechanical
stretch on endothelial cells are usually limited to two-dimensional (2D) cell culture platforms, which poorly mimic the typical three-
dimensional structure of the vessels. Therefore, the development of an advanced in vitro vasculature model that closely mimics the dynamic
of the human lung vasculatures is highly needed. Here, we present the first study that investigates the interplay of the three-dimensional
(3D) mechanical cyclic stretch and its magnitude with vascular endothelial growth factor (VEGF) stimulation on a 3D perfusable vasculature
in vitro. We studied the effects of the cyclic strain on a perfusable 3D vasculature, made of either human lung microvascular endothelial cells
or human umbilical vein endothelial cells embedded in a gel layer. The in vitro 3D vessels underwent both in vivo-like longitudinal and cir-
cumferential deformations, simultaneously. Our results showed that the responses of the human lung microvascular endothelial cells and
human umbilical vein endothelial cells to cyclic stretch were in good agreement. Although our 3D model was in agreement with the 2D
model in predicting a cytoskeletal remodeling in response to different magnitudes of cyclic stretch, however, we observed several phenomena
in the 3D model that the 2D model was unable to predict. Angiogenic sprouting induced by VEGF decreased significantly in the presence of
cyclic stretch. Similarly, while treatment with VEGF increased vascular permeability, the cyclic stretch restored vascular barrier tightness and
significantly decreased vascular permeability. One of the major findings of this study was that a 3D microvasculature can be exposed to a
much higher mechanical cyclic stress level than reported in the literature without any dysfunction of its barrier. For higher magnitudes of the
cyclic stretch, the applied longitudinal strain level was 14% and the associated circumferential strain reached the equivalent of 63%. In sharp
contrast to our findings, such strain typically leads to the disruption of the endothelial barrier in a 2D stretching assay and is considered
pathological. This highlights the importance of 3D modeling to investigate mechanobiology effects rather than using a simple endothelial
monolayer, which truly recapitulates the in vivo situation.
VC 2021 Author(s). All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://
creativecommons.org/licenses/by/4.0/). https://doi.org/10.1063/5.0010159
INTRODUCTION
The lung microvasculature is continuously exposed to mechani-
cal cyclic stretch (CS) induced by the rhythmic breathing motions and
the shear stress generated by the blood flow. These mechanical cues
act on the vascular walls and play an important role in the endothelial
barrier remodeling. Small pulmonary capillaries are particularly
exposed to lung expansion and contraction of the respiratory cycle.
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During inhalation, extra-alveolar capillaries, located outside of the
alveolar region, stretched and have an increased cross-sectional area.1
However, alveoli capillaries embedded in the air-blood barrier are
compressed between two alveoli. During exhalation, the opposite
occurs.1 The direct measurement of the vascular strain in the lung is
difficult and has not yet been reported.2 Tschumperlin et al. correlated
the lung expansion during breathing with an increase in the epithelial
cell surface.3,4 Although the extent of the stretch that pulmonary
microvascular cells undergo is not determined yet, in vitro studies
aimed at investigating endothelial cell mechanotransduction have
adopted epithelial stretch values.5–7
Endothelial mechanosensors sense and transduce cyclic strain
stimuli into biological signals. Although stretch-activated ion channels,
integrins, and platelet endothelial cell adhesion molecule-1 (PECAM-
1) are well-known endothelial mechanosensors, the precise mecha-
nism of the overall endothelial mechanotransduction is not yet
completely understood.4,8–11 Mechanical forces at the surface of endo-
thelial cells cause tyrosine phosphorylation of PECAM-1 and phos-
phorylation of extracellular signal-regulated kinase.9,11–13 PECAM-1 is
localized at the endothelial cell junctions and becomes mechanosensi-
tive when the endothelial barrier is confluent.9 Integrins are trans-
membrane cell-matrix receptors that undergo structural and
functional changes in response to mechanical force.10,14 Although the
downstream signaling pathways of integrins have been characterized,
the original molecular cascades that link integrins to these pathways
need to be elucidated. Uniaxial stretching of human pulmonary micro-
vascular endothelial cells increases the intracellular Ca2þ concentra-
tion in a strain amplitude-dependent manner for strains between 10%
and 30%.12 This finding is important as irregular Ca2þ homeostasis
caused by mechanical stretch during ventilation may play a role in the
progression of acute lung injury.15 In addition to mechanical factors,
chemical signaling can induce changes in the integrin cytoplasmic
domains. Vascular endothelial growth factor (VEGF) is, for instance, a
fundamental regulator of vascular remodeling.16 VEGF is specific to
endothelial cells and plays a unique role in preventing their apoptosis
and controlling the physiological and pathological growth of blood
vessels.17 Because of its ability to induce vascular leakage, VEGF is also
known as “vascular permeability factor.”17 These leakages take place
during the creation of vascular sprouting. VEGF disrupts cell–cell
adhesion, directs tip cell migration, determines stalk cell proliferation,
and promotes endothelial cell sprouting in the surrounding tissue.18,19
The inhibition of VEGF downregulates vascular sprouting and angio-
genesis.20 The effect of 3D CS and the interplay between CS and
VEGF in regulating vascular remodeling and angiogenesis are still not
fully understood and require sophisticated in vitro models that are
able to integrate both features.
Recently, microvasculature-on-chips gained interest to investi-
gate pathophysiological situations involving vessels.21 Among different
techniques, two strategies are common to develop these models. The
first technique is based on the self-assembly of endothelial cells with or
without mural cells to form functional three-dimensional (3D) micro-
vessels in a hydrogel matrix.22–25 This technique replicates the physio-
logical processes taking place during vasculogenesis and angiogenesis
and leads to the formation of an interconnected 3D microvascular
network. The second strategy is based on the creation of a vascular-
like pattern made of a sacrificial material.26–28 Once removed, the arti-
ficially generated tubes are perfused and seeded with endothelial cells,
which then populate the inner tube surface and form a confluent
endothelial layer.29–32 Microvasculature-on-chips have been used to
study drug toxicity and efficacy23,33 and to investigate the re-
localization of tumor cells through intra- and extravasation,34 vascular
disease modeling,35 and endothelial mechanotransduction.36
So far, the effect of the cyclic mechanical stress on the endothelial
barrier has been mostly based on 2D cell culture platforms. These plat-
forms consist of a stretchable polymeric foil on which the cells are cul-
tured and the foil can be stretched uniaxially or biaxially.6,7,9,16,37,38
Birukov and colleagues exposed human pulmonary artery endothelial
cells cultured on such membranes to different magnitudes of uniform
radial and circumferential planar strains. They observed that
thrombin-induced gap formation on the endothelial monolayer is
dependent on the magnitude of CS.38 The preconditioning monolayer
of human lung arterial endothelial cells with pathological magnitude
of planar CS (18%) significantly increased the gap surface area induced
by thrombin compared to the static condition.38
Due to the complex distribution of the strains in the lung paren-
chyma, the direct measurement of vascular strain in the lungs has not
yet been reported. Nevertheless, one usually assumes that the level of
CS to which the lung microvasculature is exposed to is similar to the
stress of the alveolar epithelium.4 In vitro studies of alveolar epithelial
cells exposed to 2D CS reported a 25% increase in the cell surface area,
which is equivalent to an 8%–12% linear strain. This corresponds to a
physiological CS, whereas a 37%–50% increase in the cell surface area
is equivalent to a 17%–22% linear strain and is related to a pathologi-
cal CS.3,38,39 Stretchable monolayers of endothelial cells are useful to
answer fundamental questions of endothelial mechanotransduction.
However, they are unable to mimic the 3D CS experienced by vessels
from cyclically expanding organs, such as the lungs, and, thus, not
suited for the study of the cyclic stretch effect on 3D microvessels.
The recent development of perfusable 3D microvascula-
ture22,23,25,40 is a milestone in vascular endothelial cell biology, as these
models much better recapitulate the in vivo situation than monolayers
of endothelial cells. They have the potential to provide a new level of
understanding of mechanobiology effects. Several of those models
aimed at investigating the effects of the shear stress generated by the
blood flow.36,41,42 Very recently, Shimizu et al. reported about the
effect of uniaxial strain on gelatin-based 3D microchannels made of
human umbilical vein endothelial cells (HUVECs).43 In this study,
simultaneous mechanical stimulation of the extra cellular matrix
(ECM)-based vasculature was developed based on the 3D culture
system of the skin equivalent capable of perfusion and stretching
stimuli.43 They showed that the combination of the fluid shear stress
and uniaxial mechanical stretch aligned HUVECs with the flow direc-
tion and the vertical direction of the stretching motion.43 This model
would be suitable to simulate the cyclic strain generated in straight
arteries.44 However, a uniaxial strain does not accurately mimic the
nature of the three-dimensional deflection experienced by the pulmo-
nary vasculature. To do so, a model able to induce simultaneous
circumferential and longitudinal strains on the vasculature is needed.
In this study, we propose for the first time a dynamic microvas-
culature platform aimed at investigating the effect of 3D CS on human
vascular remodeling. The platform incorporates a 200 um diameter
3D perfusable microvasculature located in the middle of a fibrin gel
layer, which is cyclically deflected. The vasculature exposed to this 3D
CS simultaneously experiences longitudinal and circumferential
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strains. Functional vasculatures made of human umbilical vein endo-
thelial cells (HUVECs) or human lung microvasculature cells
(VeraVecs) are reproduced and exposed to 3D cyclic mechanical
deflection. Most of the experiments were carried out with primary
HUVEC cells, easier to culture than lung microvascular endothelial
cells, and some key experiments were reproduced with the Veravecs,
exposed in vivo to the cyclic mechanical stress of the respiratory move-
ments. Additionally, the effects of different magnitudes of the CS—
physiological (low) and pathological (high)—and the interplay
between the CS and VEGF stimulation are investigated in terms of
vascular permeability, vascular sprouting, vascular morphology, cellu-
lar elongation, and cellular polarization.
RESULTS
Longitudinal and circumferential strains of vasculature
in vitro
A 200lm diameter cylindrical channel was created within a
500lm thick fibrin gel layer supported by a polydimethylsiloxane
(PDMS) membrane. RFP-labeled VeraVecs were introduced in the
channel to populate the vessel walls until the 3D confluent endothelial
barrier in the chip is reached. The assembly comprising the mem-
brane, the gel layer, and the vasculature was cyclically stretched in 3D
by applying a cyclic negative pressure in the chamber located beneath
the membrane via a house-made electro-pneumatic pump (breather).
Figure 1 shows the top and side view of a 3D vessel in static (CSzero)
and stretch (CSlow and CShigh) conditions. These images illustrate the
deflection and expansion of the vasculature under stretch and were
used to determine the vascular length and diameter. From these mea-
surements, the longitudinal and circumferential strains of the vessels
were calculated using the below equations:








In these calculations, ri is the vessel radius before stretch, rf is the
vessel radius under stretch, li is the vessel length before stretch, and lf
is the vessel length under stretch. As shown in Fig. 2(a), the longitudi-
nal strain induces an elongation of the 3D vessel, whereas the circum-
ferential strain increases the vessel perimeter. The radial strain, which
acts on the endothelial walls, was not considered as it is negligible.
Figure 2(b) shows the values of the vasculature strains under different
magnitudes of mechanical deflection. The plots reflect longitudinal
and circumferential strains of three different in vitro vessels exposed to
different magnitudes of CS and confirm that circumferential strain is
dominant for both levels of the Clow and CShigh. Finite element model-
ing of the vasculature under mechanical stretch was performed using
COMSOL. Longitudinal and circumferential displacement fields of the
vasculature under CShigh stretch were used to quantify the longitudinal
(8%) and circumferential (63%) strains as a result of simulation
(supplementary material, Fig. S1).
Cyclic stretch increases the cell length and
surface area
In vitro vasculatures reproduced either by human lung microvascu-
lar endothelial cells (VeraVecs) or by human umbilical vein endothelial
cells (HUVECs) respond to cyclic mechanical deflection by increasing
their cell surface area and elongating. VeraVecs exposed to CShigh for
24h showed a significant increase in the cell surface area (50%) and
length (80%) compared to no stress condition [Figs. 3(a) and 3(b)].
Similarly, in vitro vasculature formed by HUVECs responds to
cyclic mechanical deflection by the increased cell surface area and
length [Figs. 3(c) and 3(d)]. When exposed to CShigh, the cell surface
area increases by 43% compared to the static condition. At CSlow, the
HUVEC surface area increases by 22%, which is, however, not signifi-
cant compared to the cell surface area in the static condition (CSzero).
Cyclic stretch regulates vascular morphology
In the static condition, VeraVecs generated a confluent vascula-
ture layer with a few gaps and with cells randomly oriented on the
FIG. 1. Side and top views of a 3D vessel under CSzero, CSlow, and CShigh conditions. RFP-labeled endothelial cells were cultured in the chip and formed a 3D vessel. The ves-
sel is visualized in the static condition and under different magnitudes of stretch using confocal microscopy. Side and top views of the vessel were used to measure the vessel
length and diameter and to quantify the longitudinal and circumferential strains.
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vessel wall. However, under CShigh, the cells aligned in the direction of
the vessel and elongated. The gaps observed in the static condition dis-
appeared after being exposed to CShigh, which resulted in an increased
vascular integrity (Fig. 4).
Besides, we examined the effects of CSlow and CShigh as well as
VEGF (50ng/ml) on the morphology of the vasculature formed by
HUVECs. At CSzero, HUVECs produced a confluent vascular barrier,
but they were randomly oriented in the vasculature wall. CSlow affected
cellular orientation within the vascular wall and resulted in actin reor-
ganization and cell elongation. As expected, CShigh increased these
effects even more, by regulating vascular morphology and causing
noticeable elongation of the cells on the vasculature wall. The addition
of VEGF (50ng/ml) in the fibrin gel reduced vascular stability and
induced vascular sprouting. However, the exposure to CSlow normal-
ized the distribution of the HUVECs on the vessel wall and preserved
the stability of the VEGF-treated vasculature. When the mechanical
stretch was further increased (CShigh), the vascular stability was further
enhanced, and also, the cells elongated significantly (Fig. 5). Under
control and VEGF-treated conditions, CS-induced a cytoskeletal
remodeling on endothelial cells.
FIG. 3. The lengths (a) and surface areas (b) of lung microvascular endothelial
cells (VeraVecs) exposed to CShigh, quantified using Fiji software. The cell length
reflects the diagonal length of the cell. The effects of CSlow and CShigh on the
HUVEC length (C) and surface areas (d).
FIG. 2. (a) Schematic of a 3D vessel with radius r and length L to show the induced
strains upon 3D stretch. A longitudinal strain induces an elongation of the vessel,
rL, and a circumferential strain, rT, increases the vessel perimeter. (b) Longitudinal
and circumferential strains of three different vasculatures formed by VeraVecs
under low and high magnitudes of cyclic stretch.
FIG. 4. The effects of CShigh on the morphology of the vasculatures formed by VeraVecs. (a) Static condition and (b) exposed to CShigh. Images are overlay of the F-actin
(red) and DAPI (40 ,6-diamidino-2-phenylindole) (blue) staining. CShigh resulted in cellular elongation and increasing vascular integrity. White arrows show the locations of the
gaps on the vessel.
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Cyclic stretch upregulates endothelial adhesion
molecules
To study the effect of CS on the levels of PECAM-1, vasculatures
formed by HUVECs were immunostained against PECAM-1 and ana-
lyzed. Different magnitudes of the CS affect the levels of PECAM-1 in
cell–cell junctions. As expected, when treated with 50ng/ml of VEGF,
endothelial cells considerably reduced vascular stability by downregu-
lating PECAM-1. Our analysis of the different immunostained samples
for PECAM-1 showed that regardless of the treatment with VEGF,
even CSlow remarkably increased the level of PECAM-1 (Fig. 6).
Cyclic stretch decreases vascular permeability
The effect of CS on the permeability of the in vitro vasculatures
formed by VeraVecs and HUVECs was investigated. Figure 7 shows
the representative images of the leakage from the vasculature wall
upon CSzero and CShigh. Under static conditions, the fluorescent dye
FIG. 5. The effects of CS and VEGF (50 ng/ml) on morphology of the vasculature formed by HUVECs. For each experimental condition, images of the whole vessel showing
F-actin staining are shown. For better visualization of the vascular morphology, the overlay of the F-actin (red), PECAM-1 (green), and DAPI (blue) staining is shown as a
close-up view. Regardless of the treatment with VEGF, CS resulted in HUVEC actin re-organization, cellular elongation, and increasing vascular stability.
FIG. 6. Cyclic stretch upregulates the platelet endothelial cell adhesion molecule (PECAM-1). Left: representative images show a section of the vessel formed by HUVECs for
DAPI (blue) and PECAM-1 (green) staining in different experimental conditions. Images are Z-projection of the z-stacks from blue and green channels. Right: comparison of
PECAM-1 levels from different experimental conditions; the mean signal value of the PECAM1 was quantified in Fiji. Treatment of the HUVECs with VEGF downregulated
PECAM-1, and independent of the treatment, CSlow significantly increased PECAM-1 in the cell–cell junction.
APL Bioengineering ARTICLE scitation.org/journal/apb
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leaks into the fibrin matrix within tens of seconds. However, CShigh
decreases leakage of the fluorescent dye [70 kDa RITC (rhodamine
isothiocyanate)] into the surrounding matrix. The value of the perme-
ability coefficient reflects the leakage level of the vascular barrier. Our
results show that the leakage of the fluorescent dye (70 kDa RITC)
from the endothelial barrier formed by VeraVecs reduces significantly
upon CShigh [Fig. 8(a)].
Similarly, the exposure of the HUVEC vasculature to CS
increased vascular integrity and reduced leakage from the vascular
wall significantly [Fig. 8(b)]. Without VEGF treatment, CS signifi-
cantly decreased the endothelial barrier permeability. Besides, the
decrease in barrier permeability was also significant between CSlow
and CShigh, with the tighter wall that was obtained at high CS. VEGF
treatment (50 ng/ml) induced a noticeable vascular leakage, but con-
current exposure to CSlow normalized the vascular wall integrity and
decreased the permeability coefficient of the vessel. However, the
vascular permeability coefficients did not show any significant differ-
ence between the two conditions involving VEGF and different magni-
tudes of CS [Fig. 8(b)]. The negative control was the cylindrical cavity
without cells. The permeability coefficient across cylindrical cavity’s
wall under static and stretched conditions was compared. The leakage
of the fluorescent dye from the cylinder wall encapsulated by fibrin gel
did not change upon cyclic stretch.
Cyclic stretch suppresses vascular sprouting
Next, we examined the effects of CS and VEGF (50ng/ml) on the
endothelial sprouting of the vessel formed by HUVECs. Under the
CSzero condition, sprouting from the vessel toward the surrounding
tissue (fibrin gel) was observed. VEGF substantially prompted sprout-
ing from the HUVEC vasculature toward the surrounding gel matrix
(Fig. 9). Under control and VEGF-treated conditions, exposure to
CSlow for 24 h significantly reduced sprouting from the vessel toward
fibrin gel around the tissue (Fig. 10). These findings indicate that, in
addition to regulating the integrity and stability of the endothelial
barrier, CS suppressed vascular sprouting.
Cyclic stretch re-orients the cell nucleus
Under static conditions, the nuclei of HUVECs are randomly
oriented within the vascular wall [Fig. 11(a)]. Following exposure of
the vessel formed by HUVECs to CSlow, the nuclei were re-oriented
and took the angles between 20 andþ20 relative to the horizontal
reference line [Fig. 11(b)]. These findings indicate that, in addition to
aligning the HUVEC cytoskeleton in the direction of the vessel, 3D
mechanical CS systemically orients cell nuclei in treated (VEGF) and
untreated (control) conditions.
DISCUSSION AND CONCLUSION
Vascular barrier properties highly depend on the endothelial cell
response triggered by a variety of biochemical and/or mechanical
FIG. 7. Effect of cyclic stretch on vascular permeability. Representative images of red fluorescent dye (70 kDa RITC) leakage from the vasculature wall into the fibrin matrix.
Vasculatures formed by HUVECs were exposed to CShigh for 24 h. Under static conditions, after 60 s, fluorescent dye leaks out of the vasculature. However, high magnitudes
of cyclic stretch inhibit dye leakage from the vasculature wall.
FIG. 8. The effect of CS on vasculature formed by VeraVecs (a) and HUVECs (b).
The permeability was quantified using Fiji software based on the intensity of the
fluorescent dye around the vasculature. Also, for vasculature formed by HUVECs,
the effect of treatment with 50 ng/ml of VEGF and interplay of cyclic stretch and
treatment with VEGF on vascular permeability were investigated.
APL Bioengineering ARTICLE scitation.org/journal/apb
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stimuli. In the lungs, mechanical cyclic strains induced by breathing
motions can result in dramatic vessel remodeling and changes in the
vascular barrier functions.4,45 They are caused by cytoskeleton reorga-
nization and alterations of adherence junctions, which lead to cellular
surface area changes, loss of cell–cell contacts, and increased vascular
permeability. So far, most of our knowledge about the effects of the
cyclic mechanical stretch on endothelial cells is limited to in vitro
studies using a monolayer of endothelial cells cultured on thick
stretchable silicone rubber foils.5,7,37,38 Although a recent study investi-
gated the simultaneous effects of the shear stress and cyclic stretch
on in vitro vasculature, the setup could not expose the vasculature to
longitudinal and circumferential strain as in vivo.43 Here, we present a
functional organotypic human vasculature model that allows studying
the effects of 3D mechanical cyclic stretch (simultaneous circumferen-
tial and longitudinal strains) on vascular remodeling and endothelial
cell morphology.
Vasculatures formed by two different types of endothelial cells
were studied: human lung microvascular endothelial cells (VeraVec)
and human umbilical vein endothelial cells (HUVEC). In addition
to the standard endothelial cell model, HUVECs and VeraVecs were
tested for their response to 3D mechanical stretch. Vasculatures
formed by both cell types respond to 3D cyclic stretch by changing
the cellular morphology and the vascular barrier properties. In
this study, VeraVecs were used to show that they sense and respond to
3D mechanical stimuli as three-dimensional vessels similar to
HUVECs. HUVECs were further used to study more detailed effects
of the vascular remodeling induced by 3D cyclic stretch and VEGF
stimulation.
Our study suggests that an important cytoskeletal remodeling
takes place in response to 3D CS. In both, VeraVecs and HUVECs, CS
significantly increased the cell surface area, and it elongated and
aligned cells in the direction of the vessel (perpendicular to longitudi-
nal stress).
In our dynamic vasculature platform in vitro, vasculatures were
exposed to simultaneous longitudinal and circumferential strains simi-
lar to in vivo. The 3D vessel underwent longitudinal and circumferen-
tial strains, with the circumferential strain level being about four times
larger than that of the longitudinal strain at both low and high strain
levels. These results match very well clinical data obtained by cardiac-
gated computed tomography.46 The cyclic circumferential strain of the
human thoracic aorta was found to be four times larger than the longi-
tudinal one.46
FIG. 9. Representative images for the effects of the CS and treatment with VEGF on endothelial sprouting. Vasculature formed by HUVECs. A higher concentration of VEGF
stimulates endothelial cells and increases angiogenic sprouting from parent vasculature. Mechanical cyclic stretch normalized vascular barrier and suppresses endothelial
sprouting.
FIG. 10. The effects of CS and VEGF (50 ng/ml) on endothelial sprouting from vas-
culature formed by HUVECs. CS significantly decreased endothelial sprouting from
the vessel toward the surrounding tissue (fibrin gel).
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Another important finding is related to the morphological
response of the cells to the cyclic stretch in the form of the modifica-
tion of the cell surface area. Under CSlow, the increase in the cell sur-
face area is not significant, unlike at CShigh. According to
Tschumperlin et al.,47 the average increase in the cell surface area
under CSlow corresponds to a physiological strain and the average
increase in the cell surface area under CShigh corresponds to a patho-
logical strain. However, in sharp contrast to Birukov et al.,38 who
observed endothelial gap formation and vascular wall damage at a
high strain level (18% linear strain), we found in our 3D vascular
model that a similar strain level shows a supportive effect on the
vascular stability and barrier integrity. These findings are of high
importance, as the cyclic strain levels used for mechanobiological
studies of the alveolar epithelium47 have become the standard for
in vitro studies investigating the effect of mechanical stretch on the
endothelial barrier. According to Tschumperlin et al.,3,47 the aver-
age increase in the cell surface area under CSlow corresponds to a
linear strain of 8%–12% and the average increase in the cell surface
area under CShigh corresponds to a linear strain of 17%–22%. In
sharp contrast, in a 3D vessel, the increase in the cell surface area
under CShigh is 43% (HUVEC) and even 67% for lung endothelial
vascular cells (Table I).
FIG. 11. The effect of CS and VEGF on nucleus re-orientation. (a) Representative images of the HUVECs’ nucleus re-orientation in CSzero and CSlow conditions. The angles
between the white lines and the horizontal line show the orientation of the nuclei. (b) Under CSzero, regardless of the treatment with VEGF, HUVEC nuclei are randomly ori-
ented on the vasculature wall. However, cyclic stretch significantly re-orients the majority of cells’ nuclei, leading to orientation between 20 and þ20 related to the horizon-
tal line (direction of the vasculature length).
TABLE I. Summary of the average increase in the cell surface area and the corre-
sponding linear strain level.
CSlow CShigh
Average increase in the surface
area of HUVECs
(226 1.3) % (436 1.5) %
Average increase in the surface
area of VeraVecs
… (676 1.8) %
Corresponding linear strain level
(based on calculations from
Tschumperlin et al.47)
8%–12% 17%–22%
APL Bioengineering ARTICLE scitation.org/journal/apb
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Importantly, these high levels of strain did not lead to a dysfunc-
tion of the endothelial barrier. In contrast, at a higher cyclic stretch
level (CShigh), the barrier stability and integrity were significantly
improved compared to CSlow. This suggests the importance of recapit-
ulating the three-dimensional aspect of endothelial vessels. Therefore,
the adoption of epithelial stretch level values for endothelial cell studies
must be associated with great care.48
Endothelial cells (both HUVECs and Veravecs) cultured under
static conditions exhibit a polygonal shape and are randomly orien-
tated. However, CS induces a significant elongation and re-orientation
of the cells in a longitudinal direction and an increase in the cell sur-
face area. Endothelial cells elongate and align in the direction of the
minimal vascular deformation (longitudinal) to minimize the mechan-
ical tension.45 Interestingly, the CS induces a cell alignment regardless
of VEGF treatment. Wilkins et al. illustrated that endothelial cells,
either VEGF stimulated or not, on a 2D silicone membrane stretched
uniaxially would align perpendicular to the strain direction. Our mea-
surements of the vessel deformation subjected to CS showed that the
circumferential deformation of the vessel is larger than the longitudi-
nal deformation. Therefore, endothelial cells experience more circum-
ferential tension and, consequently, elongate in the longitudinal
direction. Similarly, endothelial cells tend to increase the cell surface
area to minimize the amount of stress exerted by the cyclic deflection.
In our 3D vasculature model, treatment with VEGF increased 3D
angiogenic sprouting. The angiogenic sprouting decreases, however,
significantly in the presence of CS in all VEGF experiments. Yung
et al. proposed that the combination of cyclic uniaxial strain (7%) and
VEGF (10ng/ml) on HUVEC-coated microcarriers in a fibrin gel
increases sprouting angiogenesis.49 Wilkins et al. reported that a com-
bination of CS and VEGF did not have a synergistic effect on endothe-
lial angiogenesis but showed that CS alone induced endothelial
sprouting. In our study, we did not observe CS-induced angiogenesis
neither with VEGF treatment nor with CS alone. Whether the differ-
ences between the reported results and our findings are due to the dif-
ferent stretch levels, VEGF concentration, cell type, or angiogenesis
assay remains to be elucidated. In vivo, however, the onset of breathing
after birth triggers both CS and flow-mediated shear stress in the pul-
monary vasculature, i.e., two mechanical signals that are considered
critical for maturation. It is tempting to speculate that our findings of
reduced sprouting upon CS resemble a stabilizing function of the
mechanical stimulation exerted on blood vessels.
A 50ng/ml VEGF treatment loosens cell–cell contacts and strik-
ingly increases vascular permeability. Independent of the treatment, CS
restores vascular barrier integrity and significantly decreases vascular
permeability. Birukova et al. assessed endothelial permeability by analy-
sis of morphological changes and measurements of transendothelial
electrical resistance and claimed that the monolayer of endothelial cells
exposed to 18% CS for 2 h to 96 h increased thrombin-induced perme-
ability.5 In this study, we did not observe CS-induced leakage on the
vascular barrier. In sharp contrast, we observed that CS strikingly
restores the endothelial barrier integrity altered by VEGF.
To the best of our knowledge, this study is the first to investigate
the interplay of VEGF and 3D CS on 3D perfusable vasculature con-
cerning vascular morphology, angiogenic sprouting, and vascular bar-
rier integrity. We showed that endothelial cells respond differently
when exposed to different magnitudes of CS. Furthermore, regardless
of the treatment with VEGF, CS increases endothelial barrier integrity,
decreases angiogenic sprouting, reorients the cells, and decreases vas-
cular barrier leakage. Advanced microvasculature-on-chip models
need to mimic the in vivo environment, including the crucial mechani-
cal and biochemical cues. Our in vitro dynamic vasculature platform
represents a powerful method that allows the investigation of CS
effects on real vessels and enables the identification of the role and
function of individual parameters of the cell culture that is not possible
in animal models. This study, however, is subjected to some potential
limitations to closely mimic physiology of the blood vessels in vitro.
Some of these limitations are lack of mural cells like pericytes besides
endothelial cell, continuous flow, and consequently shear stress in the
vessel, various durations and frequencies of the applied cyclic stretch,
gene expression analysis, and whole blood perfusion. However, the
presented dynamic vasculature platform has very high potential in
investigating these limitations in future studies. In addition, such
experimental platforms can address mechanistic questions of mecha-
notransduction and might be used for developing and optimizing drug
treatment in personalized vasculature models in the future. This is a
significant milestone in vascular endothelium research, as organ-level
information, such as vessel remodeling and functions, can for the first
time be acquired from an in vitro model and might one day be corre-
lated with clinical data.
METHODS
Device design and fabrication
The top layer of the chip had three main compartments: a 3mm
diameter central circular chamber for microvessel generation and two
reservoirs for cell seeding and medium addition connected to the cen-
tral chamber through two microchannels. The bottom layer of the
chip had a 3.5mm diameter circular chamber connected to the access
port of the breather through a microchannel. The two layers were sep-
arated by a 100lm thick membrane. Stereolithography (PROFORM,
Fribourg, Switzerland) was used to fabricate the molds of the top and
bottom layers. Polydimethylsiloxane (Sylgard, Dow Corning, USA)
was mixed at a 10:1 ratio with a curing agent, cast on the mold, and
cured at 65 C overnight. To fabricate the 100lm thick membrane,
the mixture of polydimethylsiloxane and curing agent was spin-coated
on a silicon wafer covered by a plastic sheet at 600 rpm for 60 s and
cured at 65 C overnight. After cutting and punching the pieces of dif-
ferent layers, to reproduce a cylindrical cavity in the middle of the gel,
a 200lm diameter needle was incorporated in the central chamber of
the top layer through adjusted groves. Later, the membrane was peeled
from the plastic sheet and irreversibly bonded to the top layer using
O2 plasma (Harrick Plasma, USA). Subsequently, the bottom layer
was reversibly bonded to the membrane. The breather access hole was
punched through all layers, and the multilayer was bonded to a micro-
scope slide using O2 plasma.
Cell culture
Primary HUVECs (Gibco, Life Technologies Corp. C-003–5C)
were cultured with endothelial growth medium 2 (EGM2; Lonza). For
all experiments, HUVECs were used between passages four and nine.
RFP labeled primary human lung microvascular endothelial cells
(VeraVec, Angiocrine Bioscience) were cultured in EGM2-MV
(Lonza). The cells used are commercially available, and therefore, no
ethical approval is necessary for this study. For all experiments,
VeraVecs were used between passages four and seven.
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Chip seeding and maintenance
Needle-incorporated microfluidic chips were sterilized in an
ozone chamber (CoolCLAVE, Genlantis USA) before hydrogel appli-
cation and cell seeding. A solution of 30mg/ml fibrinogen from bovine
plasma (Sigma) in phosphate-buffered saline (PBS; Gibco, Life
Technologies Corp.) was mixed with 2U/ml bovine plasma thrombin
(Sigma) in endothelial basal medium 2 (Lonza) and immediately
loaded into the central chamber of the top layer using the gel seeding
ports. After fibrin gel formation (15min), the needle was removed
from the gel layer and a cylindrical cavity was generated in the middle
of the fibrin gel layer. For the experiments with VeraVecs, they were
suspended in EGM2-MV at a final concentration of 10 106 cells/ml,
and 5ll of the cell suspension was seeded into the reproduced micro-
channel of each chip through the reservoirs. Similarly, HUVECs were
suspended in EGM2 at a final concentration of 10 106 cells/ml, and
a 5ll aliquot of the cell suspension was seeded into the microchannel
to reproduce 3D vasculature. For all experiments with VeraVecs or
HUVECs, after incubation for 30min, EGM2 or EGM2-MV was
loaded into the microchannel and the reservoirs were filled. The chips
were incubated at 37 C and 5% CO2 in Petri dishes containing a
moist tissue for humidification. The culture medium was changed
every 24 h. For some chips from the experiments with HUVECs,
50 ng/ml human VEGF165 (Miltenyi Biotec) in EGM2 was added to
the fibrin gel (from the top of the central chamber) to induce endothe-
lial sprouting.
Cyclic stretch
To cyclically stretch the polymeric membrane, and consequently
the microvessel, at a frequency of 0.2Hz, the platform was connected
to an external electro-pneumatic setup (house-made setup: breather).
The breather controlled the magnitude of the applied negative pres-
sure and the frequency. The pressure curve was modeled as a triangu-
lar wave and different magnitudes of linear strain on the membrane.
Once the confluent vascular wall was formed (day 5), the chips were
connected to the breather through the adjusted port to apply a repro-
ducible 3D cyclic strain to the cells for 24 h.
In the experiments, the negative control was a blank cylindrical
cavity without cells in the middle of the fibrin gel, which was exposed
to cyclic stretch. The effect of 24 h of mechanical cyclic stretch was
investigated on the fibrin gel layer incorporating a cylindrical cavity.
FIG. 12. Microfluidic chip for the 3D dynamic microvasculature. (a) Schematic illustration of the multilayer dynamic microvasculature platform. The main compartments of the
microfluidic chip are shown in the picture. (a) and (b) Inlet and outlet reservoirs for cell seeding and medium exchange, (c) and (d): inlet and outlet ports for fibrinogen solution
loading, (e) central chamber for the fibrin gel layer incorporating a 3D vasculature, (f) access port to the bottom layer to be connected to the pump for applying negative pres-
sure, and (g) is the groove where the needle can be inserted and removed (a small piece of tape was used to seal this groove to avoid any leakage of the fluid from the chip).
(b) The PDMS platform was plasma bonded to a microscope slide and filled with red food dye for better illustration of the compartments. It comprised two main layers sepa-
rated by a 100 lm-thick PDMS membrane. The top layer contained a central circular chamber to insert a needle from the adjusted access port and load fibrin gel to generate
a tube in the middle of the gel layer. The bottom layer had a circular chamber connected to the breather access port through a microchannel. (c) Microvasculature under differ-
ent magnitudes of CS. The deflection of the membrane was achieved by applying a negative pressure from the pump, which leads to the deformation of the gel layer including
the vasculature. Two different magnitudes of cyclic stretch were investigated to deflect the vasculature. (d) Illustration of the 3D microvasculature formed in the middle of the
fibrin gel layer.
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Establishment of a 3D stretchable microvessel
The design of the microfluidic chip comprises two polydimethyl-
siloxane (PDMS) parts, between which a 100lm thick and 3mm
diameter PDMS membrane is sandwiched. The PDMS membrane is
connected on each side, with a microfluidic channel to connect two
physiological medium reservoirs [Figs. 12(a) and 12(b)]. A 500lm
thick fibrin layer is pipetted on the PDMS membrane inside a circular
chamber incorporating a needle. After fibrinogen cross-linking and
formation of the fibrin gel, the needle is gently removed through the
adjusted groove and the opening was sealed using a piece of tape. Five
days after seeding HUVECs in the fibrin microchannel, a 3D endothe-
lial barrier (microvessel) was formed [Fig. 12(d)]. Fibrin gel loading,
needle removal, and cell seeding in the chip processes were illustrated
in an animation provided in the supplementary material (supplemen-
tary material, Video 1). The microvessel was connected to two reser-
voirs through two microchannels, aimed at providing nutrients and
reagents [Fig. 12(a)].
Immunostaining
A standard immunofluorescence protocol was used to stain the
cells. Briefly, the cells were washed with PBS and fixed with 4% para-
formaldehyde (Sigma-Aldrich) in PBS for 10min at room tempera-
ture. After three washes with PBS, 0.1% Triton X-100 (Sigma-Aldrich)
in PBS was added for 10min to permeabilize the cells and then washed
away with PBS. After blocking with 2% bovine serum albumin (BSA)
in PBS for 30min, the cells were incubated overnight with a primary
antibody against the endothelial marker PECAM-1 (Cell Signaling),
diluted 1:200 in PBS containing 2% BSA. Subsequently, the cells were
rinsed three times with PBS and then incubated with secondary anti-
bodies conjugated with 488 Alexa Fluor (Molecular Probes), as well as
phalloidin (1:100; Invitrogen) and Hoechst (1:1000; Invitrogen), for 2
h at room temperature. After several washes with PBS, images were
collected using a Zeiss LSM 710 confocal laser scanning microscope
(Carl Zeiss Microscopy, LLC).
Microvessel permeability quantification
To evaluate the effect of mechanical CS on vasculature wall integ-
rity, the vascular permeability coefficient was quantified as described
previously.41 At the end of day 6, the culture medium was removed
from the microvessel and reservoirs, and 70 kDa rhodamine
isothiocyanate-conjugated dextran (RITC, Sigma) was loaded into one
of the reservoirs at a concentration of 1mg/ml (diluted in PBS).
Imaging was started before dextran loading, and images were acquired
every 10 s using a Leica DMI 4000 microscope. The microvascular per-
meability coefficient was calculated based on the intensity of the fluo-










where DI is the initial intensity increase when RITC is loaded, dI/dt
the change in intensity of the fluorescent dye over time due to leakage
from the vessel wall, and r/2 the volume to area ratio for a cylindrical
structure (2r is the vasculature diameter). Three chips per condition
were quantified, and the whole region around the vessel was measured
per chip.
Cellular orientation quantification
Z-stacks of the cellular nuclei obtained from confocal microscopy
images of the whole vessel were divided into two and projected on a
plane with maximum signal intensity using Fiji image analysis soft-
ware to give images of the top and bottom side of each vessel.50 These
images were analyzed using the Directionality plugin in Fiji to obtain a
histogram,, indicating the orientation of the cells on the vessel wall
under static and dynamic conditions.
Measurement of the cell length and surface area
Immunofluorescence images of the vasculatures obtained fluores-
cence microscopy was used to measure the cell length and surface
area. The cell length reflects the largest diagonal length that the cell
has. It was measured by using a straight-line tool in Fiji, drawing a
diagonal line on the vessel, and measuring the length of the line. To
measure the cell surface area, the freehand selection tool in Fiji was
used to draw the boundaries around each cell and the surface area was
measured. For each vessel, 100 cells were randomly chosen for mea-
suring the cell length and surface area. The average of these cell lengths
and surfaces was considered as the average length and area of the cells
for that specific vessels and was repeated for three different vessels.
Statistical analysis and data presentation
All data are represented as the mean 6 standard deviation.
Statistically significant differences between groups were analyzed using
unpaired t-tests, and P< 0.05 was considered statistically significant.
For each quantification and statistical analysis, the minimum number
of biological samples is three (n 3). For each condition, at least three
different experiments on different days with a minimum number of
two chips were performed.
SUPPLEMENTARY MATERIAL
See the supplementary material for the finite element simulation
of the vasculature exposed to mechanical stretch. In supplementary
material Video 1, fibrin gel loading, needle removal, and cell seeding
in the chip processes are illustrated.
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